Literature DB >> 27932280

Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center.

Cosimo Bruni1, Emanuela Praino2, Serena Guiducci3, Silvia Bellando-Randone3, Daniel E Furst4, Marco Matucci-Cerinic3.   

Abstract

Entities:  

Keywords:  Arthritis; Hydroxychloroquine; Joint involvement; Pain; Systemic sclerosis; Treatment

Mesh:

Substances:

Year:  2016        PMID: 27932280     DOI: 10.1016/j.jbspin.2016.10.002

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  4 in total

Review 1.  Inflammatory arthritis in systemic sclerosis: What to do?

Authors:  Rebecca B Blank; Ogonna Kenechi Nwawka; Anna A Yusov; Jessica K Gordon
Journal:  J Scleroderma Relat Disord       Date:  2018-06-19

Review 2.  Platelets in Skin Autoimmune Diseases.

Authors:  Xiaobo Liu; Christian Gorzelanny; Stefan W Schneider
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

3.  Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy).

Authors:  Alessio Coi; Simone Barsotti; Michele Santoro; Fabio Almerigogna; Elena Bargagli; Marzia Caproni; Giacomo Emmi; Bruno Frediani; Serena Guiducci; Marco Matucci Cerinic; Marta Mosca; Paola Parronchi; Renato Prediletto; Enrico Selvi; Gabriele Simonini; Antonio Gaetano Tavoni; Fabrizio Bianchi; Anna Pierini
Journal:  Orphanet J Rare Dis       Date:  2021-02-17       Impact factor: 4.123

4.  The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress.

Authors:  Martina Orlandi; Gemma Lepri; Cosimo Bruni; Yukai Wang; Alessandro Bartoloni; Lorenzo Zammarchi; Laura Cometi; Serena Guiducci; Marco Matucci-Cerinic; Silvia Bellando-Randone
Journal:  Clin Rheumatol       Date:  2020-06-08       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.